TAYLOR DIAZ: Open Payments
NPI 1174353353 · LUTZ, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 45 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $70 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $213 |
| AstraZeneca Pharmaceuticals LP | 9 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $122 |
| PFIZER INC. | 6 | $108 |
| Amgen Inc. | 6 | $99 |
| Lilly USA, LLC | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Exact Sciences Corporation | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Hologic Sales and Service, LLC | 1 | $26 |
Products named: JARDIANCE, OTEZLA, BREZTRI, FARXIGA, Wegovy, PREVNAR 20, Ozempic, Rybelsus.
Industry payments across FL — which companies pay providers there.
